Davis Polk advised Acutus Medical on the deal. Acutus Medical, Inc. announced the sale of its left-heart access portfolio products to Medtronic, for an upfront payment of...
Medtronic’s Acquisition of Left-Heart Access Business from Acutus
ArchiMed’s $1.2 Billion Acquisition of Natus Medical
Davis Polk advised Natus Medical Incorporated on the deal, while Latham & Watkins represented ArchiMed in the transaction. ArchiMed Group executed its approximately $1.2 billion acquisition of Natus...
Charles River Laboratories’ $295 Million Acquisition of Explora BioLabs Holdings
Davis Polk advised Charles River Laboratories International on the deal. Charles River Laboratories International, Inc. announced its $295 million acquisition of Explora BioLabs Holdings, Inc. Charles...
Monarch Alternative Capital’s $150 Million Investment in The Honest Kitchen
Davis Polk advised Monarch Alternative Capital on the deal. Monarch Alternative Capital LP announced its $150 million minority investment in The Honest Kitchen. Monarch will partner...
Denali Therapeutics’ $400 Million At-The-Market Offering
Davis Polk advised the sales agents in the transaction. The transaction consists in a new SEC-registered at-the-market offering program by Denali Therapeutics Inc. under which Denali...
Ankura Consulting Group’s Acquisition of Noragh Analytics
Davis Polk advised Ankura Consulting Group, LLC on the deal. Ankura Consulting Group, LLC executed its acquisition of Noragh Analytics, Inc. Financial terms of the transaction...
Smith+Nephew’s Acquisition of Engage Surgical
Davis Polk advised Smith+Nephew on its acquisition of Engage Surgical. The cost of the acquisition is up to $135 million contingent on sales performance. Smith+Nephew is...
Senti Biosciences’ Business Combination with Dynamics Special Purpose Corp.
Goodwin Procter advised Senti Biosciences, while Davis Polk advised Dynamics Special Purpose Corp. on the deal. Senti Biosciences (“Senti Bio”) announced its definitive business combination agreement with...
Arrow Electronics’ $500 Million Senior Notes Offering
Davis Polk advised the joint book-running managers, BofA Securities BNP PARIBAS Goldman Sachs & Co. LLC, in the offering. Arrow Electronics, Inc. executed its offering of $500...
Victory Capital Holdings’ $136 Million Secondary Offering
Willkie Farr & Gallagher advised Victory Capital Holdings, while Davis Polk advised the representatives of the several underwriters in the offering. Victory Capital Holdings, Inc. announced the...
Ankura Consulting Group’s Acquisition of McLarty Associates
Davis Polk advised Ankura Consulting Group in the transaction. Ankura Consulting Group, LLC announced its acquisition of McLarty Associates. The transaction is expected to close in...
Revolution Medicines’ $250 Million Shares Offering
Davis Polk advised the sales agent, Cowen, in the offering. Revolution Medicines, Inc. announced it may issue and sell shares of its common stock for up...